Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Genevieve Durrieu

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Therapie|April 1, 2018
Pediatric pharmacologyFlorentia Kaguelidou, Behrouz Kassai Koupai, Genevieve Durrieu
Pharmacoepidemiology and Drug Safety|December 14, 2011
A comparative study of adverse drug reactions during two heat waves that occurred in France in 2003 and 2006Agnès Sommet, Genevieve Durrieu, Maryse Lapeyre-Mestre, et al.
Bulletin De L'Academie Nationale De Medecine|September 10, 2005
[New methods for studying drug associated risk: experience of the Toulouse Regional Pharmacovigilance Center]Jean-Louis Montastruc, Haleh Bagheri, Isabelle Lacroix, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 10, 2010
Neuropathy as a potential complication of levodopa use in Parkinson's disease: a pharmacological and pharmacovigilance point of viewJean-Louis Montastruc, Anne Charlotte Danton, Genevieve Durrieu, et al.
European Journal of Clinical Pharmacology|April 29, 2021
Drugs and Dupuytren's disease: a pharmacovigilance study in VigiBase®Jean-Louis Montastruc, Julia Guion-Firmin, Claire de Canecaude, et al.
European Journal of Clinical Pharmacology|December 15, 2010
Safety surveillance of influenza A(H1N1)v monovalent vaccines during the 2009-2010 mass vaccination campaign in FranceCéline Caillet, Genevieve Durrieu, Alexis Jacquet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 31, 2016
Atropinic (Anticholinergic) Burden in Parkinson's DiseaseSibylle De Germay, Jean-Louis Montastruc, Vanessa Rousseau, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Therapie|April 1, 2018
Pediatric pharmacologyFlorentia Kaguelidou, Behrouz Kassai Koupai, Genevieve Durrieu
Pharmacoepidemiology and Drug Safety|December 14, 2011
A comparative study of adverse drug reactions during two heat waves that occurred in France in 2003 and 2006Agnès Sommet, Genevieve Durrieu, Maryse Lapeyre-Mestre, et al.
Bulletin De L'Academie Nationale De Medecine|September 10, 2005
[New methods for studying drug associated risk: experience of the Toulouse Regional Pharmacovigilance Center]Jean-Louis Montastruc, Haleh Bagheri, Isabelle Lacroix, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 10, 2010
Neuropathy as a potential complication of levodopa use in Parkinson's disease: a pharmacological and pharmacovigilance point of viewJean-Louis Montastruc, Anne Charlotte Danton, Genevieve Durrieu, et al.
European Journal of Clinical Pharmacology|April 29, 2021
Drugs and Dupuytren's disease: a pharmacovigilance study in VigiBase®Jean-Louis Montastruc, Julia Guion-Firmin, Claire de Canecaude, et al.
European Journal of Clinical Pharmacology|December 15, 2010
Safety surveillance of influenza A(H1N1)v monovalent vaccines during the 2009-2010 mass vaccination campaign in FranceCéline Caillet, Genevieve Durrieu, Alexis Jacquet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 31, 2016
Atropinic (Anticholinergic) Burden in Parkinson's DiseaseSibylle De Germay, Jean-Louis Montastruc, Vanessa Rousseau, et al.
Pageof 1